The aim of the study was to investigate the role of high-risk human papillomavirus (HR-HPV) infection in the etiopathogenesis of oral (OSCC) and oropharyngeal (OPSCC) squamous cell carcinoma in non-smoking and non-drinking patients (NSNDP). Twenty-four OSCCs and 22 OPSCCs were analyzed by immunohistochemistry for p16(INK4a) protein (p16) expression and by chromogene in situ hybridization (CISH) and polymerase chain reaction (PCR) for HR-HPV DNA presence. The series included 23 males and 23 females aged 35-93 years. p16 expression was seen in 7 out of 24 (29%) OSCCs and in 22 out of 22 (100%) OPSCCs. Using CISH, HR-HPV DNA was observed in 6 out of 24 (25%) OSCCs and in 21 out of 22 (95%) OPSCCs. HPV DNA was found in 3 out of 24 (13%) OSCCs and in 18 out of 22 (82%) OPSCCs using PCR. HPV 16 and 33 were detected in 16 and in two cases, respectively. Compared with OSCCs, OPSCCs more frequently showed basaloid morphology (p < 0.0001), lymph node involvement (p = 0.0063), diffuse p16 expression (p < 0.0001), HR-HPV DNA presence using both CISH and PCR (p < 0.0001; p < 0.0001), and better outcome. The sensitivity and specificity of p16 expression for HR-HPV DNA presence detected by CISH were 0.89 and 0.95, respectively, and 0.95 and 0.85 for PCR detected HPV DNA. The sensitivity and specificity of CISH for PCR detected presence of HPV DNA were 1.00 and 0.73, respectively. Our study is the first larger study analyzing OSCC and OPSCC in NSNDP. Our results indicate that unlike OSCC, a vast majority of OPSCCs may be associated with HR-HPV infection.

The Fingerland Department of Pathology Faculty of Medicine and Faculty Hospital in Hradec Kralove Charles University Sokolská 581 500 05 Hradec Králové Czech Republic

Zobrazit více v PubMed

Gynecol Oncol. 2008 Mar;108(3):555-60 PubMed

J Oral Pathol Med. 2008 Nov;37(10):593-8 PubMed

Laryngoscope. 2009 Oct;119(10):1951-7 PubMed

Ann Otol Rhinol Laryngol. 2009 Oct;118(10):742-9 PubMed

Int J Cancer. 2005 Mar 1;113(6):946-50 PubMed

APMIS. 2010 Jun;118(6-7):510-9 PubMed

Pathol Res Pract. 2008;204(8):545-52 PubMed

Eur J Cancer. 2002 Nov;38(17):2229-42 PubMed

Int J Biol Markers. 2009 Oct-Dec;24(4):215-22 PubMed

Oral Oncol. 2008 Oct;44(10):915-9 PubMed

Int J Cancer. 2009 Jul 15;125(2):362-6 PubMed

J Clin Oncol. 2006 Feb 10;24(5):736-47 PubMed

Int J Oral Maxillofac Surg. 2007 Feb;36(2):153-8 PubMed

Arch Otolaryngol Head Neck Surg. 2009 Feb;135(2):180-8 PubMed

Semin Oncol. 2004 Dec;31(6):744-54 PubMed

N Engl J Med. 2007 May 10;356(19):1944-56 PubMed

Klin Onkol. 2008;21(4):141-8 PubMed

QJM. 2010 Apr;103(4):229-36 PubMed

Int J Cancer. 1985 Nov 15;36(5):575-8 PubMed

Eur Arch Otorhinolaryngol. 2008 Jul;265 Suppl 1:S75-82 PubMed

J Invest Dermatol. 1985 May;84(5):417-20 PubMed

Eur J Cancer B Oral Oncol. 1996 Jan;32B(1):55-62 PubMed

Int J Cancer. 2004 Feb 20;108(5):766-72 PubMed

Virology. 2009 Feb 20;384(2):260-5 PubMed

Acta Otorhinolaryngol Ital. 2009 Jun;29(3):119-26 PubMed

Nat Rev Cancer. 2002 May;2(5):342-50 PubMed

J Natl Cancer Inst. 1998 Nov 4;90(21):1626-36 PubMed

Oral Dis. 2005 May;11(3):181-5 PubMed

Pathol Res Pract. 2010 Apr 15;206(4):229-34 PubMed

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):701-9 PubMed

Oncology. 2009;76(3):205-8 PubMed

Int J Oral Surg. 1983 Dec;12(6):418-24 PubMed

Otolaryngol Head Neck Surg. 2009 Sep;141(3):382-9 PubMed

MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study

The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis